Literature DB >> 26363654

Antegrade or Retrograde Cerebral Perfusion in Ascending Aorta and Hemiarch Surgery? A Propensity-Matched Analysis.

Konstantinos Perreas1, George Samanidis2, Apostolis Thanopoulos3, Georgios Georgiopoulos4, Theofani Antoniou3, Mazen Khoury5, Alkiviadis Michalis5, Andreas Bairaktaris1.   

Abstract

BACKGROUND: Over the years, numerous options have been proposed for surgical management of ascending aorta and aortic arch pathology in an attempt to minimize postoperative morbidity and probability of death. We present a propensity score-matching analysis of 259 patients from a single unit who were operated on under deep hypothermic arrest with retrograde cerebral perfusion (DHCA/RCP) or moderate hypothermic circulatory arrest with selective antegrade cerebral perfusion (via common carotid artery) (MHCA/ACP).
METHODS: Between 2006 and 2014 a total of 259 consecutive patients underwent ascending aorta and hemiarch correction under HCA. DHCA/RCP and MHCA/ACP were performed on 207 and 52 patients, respectively. Baseline patient characteristics accounted for in the propensity matching were age, sex, acute aortic dissection, emergency operation, re-operation, preoperative hemodynamic instability, preoperative kidney injury, and CA time. After propensity scoring 40 pairs (80 patients) were successfully matched (p = 0.732). Outcomes were defined as the incidence of postoperative neurologic complications, 30-day mortality, and all-cause midterm mortality.
RESULTS: Surgical procedure that involved the MHCA/ACP technique was associated with 76.5% decreased risk (risk ratio, 0.235; 95% CI, 0.079 to 0.699) of postoperative neurologic complications (p = 0.009). In addition to MHCA/ACP in surgical procedure for acute aortic dissection a relevant trend was established for 30-day mortality (risk ratio, 0.333; 95% CI, 0.09 to 1.23). For midterm all-cause mortality, MHCA/ACP modestly decreased the number of deaths (p = 0.0456) in comparison with the DHCA/RCP technique.
CONCLUSIONS: MHCA/ACP in aortic arch surgical procedure is associated with a decreased risk of all types of neurologic complications and a trend toward decreased 30-day and midterm mortality in comparison with DHCA/RCP.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26363654     DOI: 10.1016/j.athoracsur.2015.06.029

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

Review 1.  Intraoperative care for aortic surgery using circulatory arrest.

Authors:  Félix Ezequiel Fernández Suárez; David Fernández Del Valle; Adrián González Alvarez; Blanca Pérez-Lozano
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Con-debate: short circulatory arrest times in arch reconstructive surgery: is simple retrograde cerebral perfusion or hypothermic circulatory arrest as good or better than complex antegrade cerebral perfusion for open distal involvement or hemi-arch?

Authors:  Luca Di Marco; Giacomo Murana; Alessandro Leone; Davide Pacini
Journal:  J Vis Surg       Date:  2018-03-08

3.  Regional Practice Patterns and Outcomes of Surgery for Acute Type A Aortic Dissection.

Authors:  Robert B Hawkins; J Hunter Mehaffey; Emily A Downs; Lily E Johnston; Leora T Yarboro; Clifford E Fonner; Alan M Speir; Jeffrey B Rich; Mohammed A Quader; Gorav Ailawadi; Ravi K Ghanta
Journal:  Ann Thorac Surg       Date:  2017-06-06       Impact factor: 4.330

4.  Deep Hypothermic Circulatory Arrest vs. Antegrade Cerebral Perfusion in Cerebral Protection during the Surgical Treatment of Chronic Dissection of the Ascending and Arch Aorta.

Authors:  Oksana Vasilyevna Kamenskaya; Asya Stanislavovna Klinkova; Alexander Mikhailovich Chernyavsky; Vladimir Vladimirovich Lomivorotov; Ivan Olegovich Meshkov; Alexander Mikhailovich Karaskov
Journal:  J Extra Corpor Technol       Date:  2017-03

5.  Influence of moderate hypothermic circulatory arrest on outcome in patients undergoing elective replacement of thoracic aorta.

Authors:  Mohamed Salem; Christine Friedrich; Alexander Thiem; Mostafa Ahmed Salem; Yasemin Erdal; Thomas Puehler; Rene Rusch; Rouven Berndt; Jochen Cremer; Assad Haneya
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

Review 6.  Goal-directed cerebral perfusion in aortic arch surgery: scientific leap or hype?

Authors:  Xiaoying Lou; Edward P Chen
Journal:  Asian Cardiovasc Thorac Ann       Date:  2020-05-21

7.  Axillary versus innominate artery cannulation for antegrade cerebral perfusion in aortic surgery: design of the Aortic Surgery Cerebral Protection Evaluation (ACE) CardioLink-3 randomised trial.

Authors:  Vinay Garg; Mark D Peterson; Michael Wa Chu; Maral Ouzounian; Roderick Gg MacArthur; John Bozinovski; Ismail El-Hamamsy; F Victor Chu; Ankit Garg; Judith Hall; Kevin E Thorpe; Natasha Dhingra; Hwee Teoh; Thomas R Marotta; David A Latter; Adrian Quan; Muhammad Mamdani; Peter Juni; C David Mazer; Subodh Verma
Journal:  BMJ Open       Date:  2017-06-10       Impact factor: 2.692

8.  Simplified surgical approach to improve surgical outcomes in the center with a small volume of acute type A aortic dissection surgery.

Authors:  Jong Hun Kim; Jong Bum Choi; Tae Youn Kim; Kyung Hwa Kim; Ja Hong Kuh
Journal:  Technol Health Care       Date:  2018       Impact factor: 1.285

9.  Effect of moderate hypothermic circulatory arrest on neurological outcomes in elderly patients undergoing replacement of the thoracic aorta.

Authors:  Mohamed Salem; Christine Friedrich; Alexander Thiem; Mostafa Ahmed Salem; Thomas Puehler; Rene Rusch; Rouven Berndt; Jochen Cremer; Assad Haneya
Journal:  Egypt Heart J       Date:  2020-03-30

10.  Surgical rescues for critical hemopericardium complicated by acute type A aortic dissection: Emergent subxiphoid pericardiotomy or cardiopulmonary bypass first?

Authors:  Chun-Yu Lin; Meng-Yu Wu; Chi-Nan Tseng; Yu-Sheng Chang; Yuan-Chang Liu; Cheng-Hui Lu; Feng-Chun Tsai
Journal:  PLoS One       Date:  2020-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.